Yeast-Based Drug Discovery:

The humanized yeast model has emerged as a powerful tool in large-scale screenings directed to target human proteins. The high degree of cellular processes conservation between the yeast Saccharomyces cerevisiae and higher eukaryotes has made this microorganism a valuable cell model to study the pathobiology of several human diseases. The yeast target-based approach can be highly useful in the first-line screening of potentially active compounds to be tested in more complex cell models.

 

 

  • Yeast as a model for human diseases and drug testing

Related Conference of Yeast-Based Drug Discovery:

December 04-05, 2019

Orthodontics and Prosthodontics

Tokyo, Japan
April 06 - 07, 2020

12th Global Summit on Immunology and Cell Biology

Manila, Philippines
June 15-16, 2020

49th World Congress on Microbiology

London, UK
June 24-25, 2020

12th International Virology Summit

Rome, Italy
July 20-21,2020

4th World Congress on Beneficial Microbes

Montreal, Canada
September 01-02, 2020

5th International Conference on Bacteriology

Barcelona, Spain
September 28-29, 2020

8th World Congress and Expo on Applied Microbiology

Barcelona, Spain
November 25-26, 2020

18th Asia Pacific Pathology Congress

Tokyo, Japan

Yeast-Based Drug Discovery: Conference Speakers

Recommended Sessions

Related Journals

Are you interested in